Switch to:

Arrowhead Pharmaceuticals Total Assets

: $555.7 Mil (As of Jun. 2020)
View and export this data going back to 1997. Start your Free Trial

Arrowhead Pharmaceuticals's Total Assets for the quarter that ended in Jun. 2020 was $555.7 Mil.

During the past 12 months, Arrowhead Pharmaceuticals's average Total Assets Growth Rate was 168.90% per year. During the past 3 years, the average Total Assets Growth Rate was 28.60% per year. During the past 5 years, the average Total Assets Growth Rate was 18.10% per year. During the past 10 years, the average Total Assets Growth Rate was 31.10% per year.

During the past 13 years, Arrowhead Pharmaceuticals's highest 3-Year average Total Assets Growth Rate was 420.80%. The lowest was -18.50%. And the median was 22.25%.

Total Assets is connected with ROA %. Arrowhead Pharmaceuticals's annualized ROA % for the quarter that ended in Jun. 2020 was -9.75%. Total Assets is also linked to Revenue through Asset Turnover. Arrowhead Pharmaceuticals's Asset Turnover for the quarter that ended in Jun. 2020 was 0.05.


Arrowhead Pharmaceuticals Total Assets Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Arrowhead Pharmaceuticals Annual Data
Sep10 Sep11 Sep12 Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19
Total Assets Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 132.27 128.18 104.02 111.61 349.85

Arrowhead Pharmaceuticals Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
Total Assets Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 336.83 349.85 587.60 561.08 555.73

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Arrowhead Pharmaceuticals Total Assets Distribution

* The bar in red indicates where Arrowhead Pharmaceuticals's Total Assets falls into.



Arrowhead Pharmaceuticals Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Arrowhead Pharmaceuticals's Total Assets for the fiscal year that ended in Sep. 2019 is calculated as

Total Assets=Total Equity (A: Sep. 2019 )+Total Liabilities (A: Sep. 2019 )
=244.036+105.809
=349.8

Arrowhead Pharmaceuticals's Total Assets for the quarter that ended in Jun. 2020 is calculated as

Total Assets=Total Equity (Q: Jun. 2020 )+Total Liabilities (Q: Jun. 2020 )
=492.585+63.143
=555.7

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Arrowhead Pharmaceuticals  (NAS:ARWR) Total Assets Explanation

Total Assets is connected with ROA %.

Arrowhead Pharmaceuticals's annualized ROA % for the quarter that ended in Jun. 2020 is

ROA %=Net Income (Q: Jun. 2020 )/( (Total Assets (Q: Mar. 2020 )+Total Assets (Q: Jun. 2020 ))/ count )
=-54.444/( (561.076+555.728)/ 2 )
=-54.444/558.402
=-9.75 %

Note: The Net Income data used here is four times the quarterly (Jun. 2020) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Arrowhead Pharmaceuticals's Asset Turnover for the quarter that ended in Jun. 2020 is

Asset Turnover
=Revenue (Q: Jun. 2020 )/( (Total Assets (Q: Mar. 2020 )+Total Assets (Q: Jun. 2020 ))/ count )
=27.376/( (561.076+555.728)/ 2 )
=27.376/558.402
=0.05

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Arrowhead Pharmaceuticals Total Assets Related Terms


Arrowhead Pharmaceuticals Total Assets Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)